Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-25

Clinical Trial Update: Utilizing MRI to Study the Effect of Sulforaphane on Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update reports that the MRI-based study of sulforaphane for prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforaphane (sulforaphane)

Snippet

Sponsor: Quadram Institute Bioscience | Conditions: Prostate Cancer | NA | Status: TERMINATED